HomeClinical TopicsFDA approves first drug for treating Duchenne muscular dystrophy

FDA approves first drug for treating Duchenne muscular dystrophy

On Sept. 19, the Food and Drug Administration (FDA) approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content